Unknown

Dataset Information

0

Dose-risk and duration-risk relationships between aspirin and colorectal cancer: a meta-analysis of published cohort studies.


ABSTRACT:

Background

In previous meta-analyses, aspirin use has been associated with reduced risk of colorectal cancer. However, uncertainty remains on the exact dose-risk and duration-risk relationships.

Methods

We identified studies by searching several English and Chinese electronic databases and reviewing relevant articles. The dose-response meta-analysis was performed by linear trend regression and restricted cubic spline regression. Subgroup analyses were conducted to explore possible heterogeneity among studies. Potential heterogeneity was calculated as Q statistic and I(2) value. Publication bias was evaluated using funnel plots and quantified by the Begg's and Egger's test.

Results

Twelve studies were included in this meta-analysis. An inverse association between aspirin use and colorectal cancer was observed in both the overall group (RR?=?0.74, 95% CI 0.64-0.83 for aspirin dose; RR?=?0.80, 95% CI 0.75-0.85 for frequency of aspirin use; RR?=?0.75, 95% CI 0.68-0.81 for years of aspirin use) and subgroups stratified by sex and cancer site. The dose-response meta-analysis showed that there was a 20% statistically significant decreased risk of colorectal cancer for 325 mg aspirin per day increment, 18% decreased risk for 7 times aspirin per week increment and 18% decreased risk for 10 years aspirin increment.

Conclusion

Long-term (>5 years), low-dose (75-325 mg per day) and regular aspirin use (2-7 times per week) can effectively reduce the risk of colorectal cancer.

SUBMITTER: Ye X 

PROVIDER: S-EPMC3581483 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

altmetric image

Publications

Dose-risk and duration-risk relationships between aspirin and colorectal cancer: a meta-analysis of published cohort studies.

Ye Xiaohua X   Fu Jinjian J   Yang Yi Y   Chen Sidong S  

PloS one 20130225 2


<h4>Background</h4>In previous meta-analyses, aspirin use has been associated with reduced risk of colorectal cancer. However, uncertainty remains on the exact dose-risk and duration-risk relationships.<h4>Methods</h4>We identified studies by searching several English and Chinese electronic databases and reviewing relevant articles. The dose-response meta-analysis was performed by linear trend regression and restricted cubic spline regression. Subgroup analyses were conducted to explore possible  ...[more]

Similar Datasets

| S-EPMC3728206 | biostudies-literature
| S-EPMC5868628 | biostudies-literature
| S-EPMC4633618 | biostudies-literature
| S-EPMC2939779 | biostudies-literature
| S-EPMC3762769 | biostudies-literature
| S-EPMC8279749 | biostudies-literature
| S-EPMC4747545 | biostudies-literature
| S-EPMC5684291 | biostudies-literature
| S-EPMC3787107 | biostudies-literature
| S-EPMC8137614 | biostudies-literature